Regeneron Prevails Over Amgen in PCSK9 Litigation; 2 Cell Therapy Biotechs Implement Workforce Reductions

Regeneron Prevails Over Amgen in PCSK9 Litigation; 2 Cell Therapy Biotechs Implement Workforce Reductions

Regeneron Prevails Over Amgen in PCSK9 Litigation; 2 Cell Therapy Biotechs Implement Workforce Reductions